152 results
424B5
ABBV
Abbvie Inc
26 Feb 24
Prospectus supplement for primary offering
6:12am
to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
AbbVie’s products … , aesthetics and eye care. AbbVie uses its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies
424B5
ABBV
Abbvie Inc
21 Feb 24
Prospectus supplement for primary offering
8:39am
expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex … and eye care. AbbVie uses its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some
8-K
EX-99.1
t1hjl0bf
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
EX-99.1
o32z5iy
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
PX14A6G
z36hkaeg4kg58wxsmoyb
4 May 23
Letter to shareholders
8:08am
8-K
9p63aqmo5niu5ugi
13 Apr 22
Departure of Directors or Certain Officers
9:15am
PX14A6G
2g0gg3k dzwdi3
11 Apr 22
Letter to shareholders
4:35pm
S-3ASR
jtcl267jcp5j5
22 Feb 22
Automatic shelf registration
5:02pm